We found that NICD3 was positively regulated by P53mt (Figure 5A and Figure S7B), suggesting that p53 mutation may up‐regulate CCNG1 and Notch3 expression in ovarian cancer. This evidence concerns the gene TP53 and ovarian carcinoma.